nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—Sulfasalazine—Crohn's disease	0.158	0.55	CbGbCtD
Lansoprazole—CYP2C19—Prednisone—Crohn's disease	0.0564	0.197	CbGbCtD
Lansoprazole—ABCB1—Prednisone—Crohn's disease	0.0455	0.159	CbGbCtD
Lansoprazole—CYP3A4—Prednisone—Crohn's disease	0.0273	0.095	CbGbCtD
Lansoprazole—ATP4B—digestive system—Crohn's disease	0.00762	0.152	CbGeAlD
Lansoprazole—ATP4A—epithelium—Crohn's disease	0.00436	0.0871	CbGeAlD
Lansoprazole—CYP4A11—digestive system—Crohn's disease	0.00411	0.0822	CbGeAlD
Lansoprazole—ATP4A—digestive system—Crohn's disease	0.00331	0.0663	CbGeAlD
Lansoprazole—CYP2C18—mammalian vulva—Crohn's disease	0.00311	0.0621	CbGeAlD
Lansoprazole—CYP2C18—digestive system—Crohn's disease	0.00272	0.0545	CbGeAlD
Lansoprazole—MAPT—lymph node—Crohn's disease	0.00255	0.051	CbGeAlD
Lansoprazole—CYP1A1—mouth—Crohn's disease	0.00211	0.0421	CbGeAlD
Lansoprazole—CYP1B1—smooth muscle tissue—Crohn's disease	0.00167	0.0334	CbGeAlD
Lansoprazole—CYP1B1—skin of body—Crohn's disease	0.00165	0.033	CbGeAlD
Lansoprazole—CYP1B1—lymphoid tissue—Crohn's disease	0.00134	0.0267	CbGeAlD
Lansoprazole—CYP1B1—digestive system—Crohn's disease	0.00132	0.0264	CbGeAlD
Lansoprazole—CYP1A1—epithelium—Crohn's disease	0.00123	0.0245	CbGeAlD
Lansoprazole—CYP1A1—skin of body—Crohn's disease	0.00117	0.0233	CbGeAlD
Lansoprazole—Anorexia—Mercaptopurine—Crohn's disease	0.00116	0.00178	CcSEcCtD
Lansoprazole—CYP2C19—digestive system—Crohn's disease	0.00116	0.0231	CbGeAlD
Lansoprazole—Eosinophilia—Mesalazine—Crohn's disease	0.00115	0.00177	CcSEcCtD
Lansoprazole—Pneumonia—Azathioprine—Crohn's disease	0.00115	0.00176	CcSEcCtD
Lansoprazole—Pancreatitis—Mesalazine—Crohn's disease	0.00114	0.00175	CcSEcCtD
Lansoprazole—Infestation—Azathioprine—Crohn's disease	0.00114	0.00175	CcSEcCtD
Lansoprazole—Infestation NOS—Azathioprine—Crohn's disease	0.00114	0.00175	CcSEcCtD
Lansoprazole—Angina pectoris—Mesalazine—Crohn's disease	0.00113	0.00174	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00113	0.00173	CcSEcCtD
Lansoprazole—Contusion—Prednisone—Crohn's disease	0.00112	0.00173	CcSEcCtD
Lansoprazole—ABCG2—mammalian vulva—Crohn's disease	0.00112	0.0224	CbGeAlD
Lansoprazole—Bronchitis—Mesalazine—Crohn's disease	0.00112	0.00172	CcSEcCtD
Lansoprazole—Abdominal discomfort—Mesalazine—Crohn's disease	0.00112	0.00171	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00111	0.00171	CcSEcCtD
Lansoprazole—Pancytopenia—Mesalazine—Crohn's disease	0.00111	0.0017	CcSEcCtD
Lansoprazole—Neutropenia—Mesalazine—Crohn's disease	0.00109	0.00167	CcSEcCtD
Lansoprazole—Dysuria—Mesalazine—Crohn's disease	0.00109	0.00167	CcSEcCtD
Lansoprazole—Viral infection—Prednisone—Crohn's disease	0.00109	0.00167	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00108	0.00166	CcSEcCtD
Lansoprazole—Arthropathy—Prednisone—Crohn's disease	0.00108	0.00166	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00108	0.00165	CcSEcCtD
Lansoprazole—Pollakiuria—Mesalazine—Crohn's disease	0.00108	0.00165	CcSEcCtD
Lansoprazole—CYP1A1—mammalian vulva—Crohn's disease	0.00106	0.0213	CbGeAlD
Lansoprazole—Agranulocytosis—Azathioprine—Crohn's disease	0.00106	0.00163	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00106	0.00163	CcSEcCtD
Lansoprazole—Decreased appetite—Mercaptopurine—Crohn's disease	0.00106	0.00163	CcSEcCtD
Lansoprazole—Weight increased—Mesalazine—Crohn's disease	0.00106	0.00163	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00105	0.00162	CcSEcCtD
Lansoprazole—Pneumonia—Mesalazine—Crohn's disease	0.00104	0.0016	CcSEcCtD
Lansoprazole—Infestation—Mesalazine—Crohn's disease	0.00104	0.00159	CcSEcCtD
Lansoprazole—Infestation NOS—Mesalazine—Crohn's disease	0.00104	0.00159	CcSEcCtD
Lansoprazole—Ulcer—Prednisone—Crohn's disease	0.00104	0.00159	CcSEcCtD
Lansoprazole—Cataract—Prednisone—Crohn's disease	0.00103	0.00158	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00103	0.00158	CcSEcCtD
Lansoprazole—Renal failure—Mesalazine—Crohn's disease	0.00102	0.00157	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00102	0.00156	CcSEcCtD
Lansoprazole—Jaundice—Mesalazine—Crohn's disease	0.00101	0.00155	CcSEcCtD
Lansoprazole—Stomatitis—Mesalazine—Crohn's disease	0.00101	0.00155	CcSEcCtD
Lansoprazole—Urinary tract infection—Mesalazine—Crohn's disease	0.00101	0.00155	CcSEcCtD
Lansoprazole—Conjunctivitis—Mesalazine—Crohn's disease	0.00101	0.00155	CcSEcCtD
Lansoprazole—Sweating—Mesalazine—Crohn's disease	0.000995	0.00153	CcSEcCtD
Lansoprazole—Haematuria—Mesalazine—Crohn's disease	0.000989	0.00152	CcSEcCtD
Lansoprazole—Hiccups—Prednisone—Crohn's disease	0.000981	0.00151	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000981	0.00151	CcSEcCtD
Lansoprazole—Epistaxis—Mesalazine—Crohn's disease	0.000979	0.0015	CcSEcCtD
Lansoprazole—Sinusitis—Mesalazine—Crohn's disease	0.000973	0.00149	CcSEcCtD
Lansoprazole—Agranulocytosis—Mesalazine—Crohn's disease	0.000968	0.00149	CcSEcCtD
Lansoprazole—Erythema multiforme—Azathioprine—Crohn's disease	0.000967	0.00148	CcSEcCtD
Lansoprazole—Body temperature increased—Mercaptopurine—Crohn's disease	0.000964	0.00148	CcSEcCtD
Lansoprazole—CYP1A2—digestive system—Crohn's disease	0.000946	0.0189	CbGeAlD
Lansoprazole—Rhinitis—Mesalazine—Crohn's disease	0.000934	0.00143	CcSEcCtD
Lansoprazole—CYP1A1—digestive system—Crohn's disease	0.000933	0.0186	CbGeAlD
Lansoprazole—Hepatitis—Mesalazine—Crohn's disease	0.000932	0.00143	CcSEcCtD
Lansoprazole—Pharyngitis—Mesalazine—Crohn's disease	0.000925	0.00142	CcSEcCtD
Lansoprazole—Immune system disorder—Azathioprine—Crohn's disease	0.000924	0.00142	CcSEcCtD
Lansoprazole—Mediastinal disorder—Azathioprine—Crohn's disease	0.000922	0.00141	CcSEcCtD
Lansoprazole—Neuropathy—Prednisone—Crohn's disease	0.000921	0.00141	CcSEcCtD
Lansoprazole—Urinary tract disorder—Mesalazine—Crohn's disease	0.00092	0.00141	CcSEcCtD
Lansoprazole—Oedema peripheral—Mesalazine—Crohn's disease	0.000918	0.00141	CcSEcCtD
Lansoprazole—Chills—Azathioprine—Crohn's disease	0.000918	0.00141	CcSEcCtD
Lansoprazole—Connective tissue disorder—Mesalazine—Crohn's disease	0.000915	0.00141	CcSEcCtD
Lansoprazole—Arrhythmia—Azathioprine—Crohn's disease	0.000914	0.0014	CcSEcCtD
Lansoprazole—Urethral disorder—Mesalazine—Crohn's disease	0.000913	0.0014	CcSEcCtD
Lansoprazole—Alopecia—Azathioprine—Crohn's disease	0.000904	0.00139	CcSEcCtD
Lansoprazole—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000898	0.00138	CcSEcCtD
Lansoprazole—CYP2C9—digestive system—Crohn's disease	0.000898	0.0179	CbGeAlD
Lansoprazole—Oesophagitis—Prednisone—Crohn's disease	0.000897	0.00138	CcSEcCtD
Lansoprazole—Erythema multiforme—Mesalazine—Crohn's disease	0.000881	0.00135	CcSEcCtD
Lansoprazole—Eye disorder—Mesalazine—Crohn's disease	0.000871	0.00134	CcSEcCtD
Lansoprazole—Tinnitus—Mesalazine—Crohn's disease	0.000868	0.00133	CcSEcCtD
Lansoprazole—Cardiac disorder—Mesalazine—Crohn's disease	0.000865	0.00133	CcSEcCtD
Lansoprazole—Hyperkinesia—Prednisone—Crohn's disease	0.000856	0.00131	CcSEcCtD
Lansoprazole—Angiopathy—Mesalazine—Crohn's disease	0.000845	0.0013	CcSEcCtD
Lansoprazole—Immune system disorder—Mesalazine—Crohn's disease	0.000841	0.00129	CcSEcCtD
Lansoprazole—Mediastinal disorder—Mesalazine—Crohn's disease	0.00084	0.00129	CcSEcCtD
Lansoprazole—Chills—Mesalazine—Crohn's disease	0.000836	0.00128	CcSEcCtD
Lansoprazole—Diarrhoea—Mercaptopurine—Crohn's disease	0.000834	0.00128	CcSEcCtD
Lansoprazole—Ill-defined disorder—Azathioprine—Crohn's disease	0.000826	0.00127	CcSEcCtD
Lansoprazole—Alopecia—Mesalazine—Crohn's disease	0.000823	0.00126	CcSEcCtD
Lansoprazole—Anaemia—Azathioprine—Crohn's disease	0.000823	0.00126	CcSEcCtD
Lansoprazole—Diabetes mellitus—Prednisone—Crohn's disease	0.000819	0.00126	CcSEcCtD
Lansoprazole—Mental disorder—Mesalazine—Crohn's disease	0.000816	0.00125	CcSEcCtD
Lansoprazole—Erythema—Mesalazine—Crohn's disease	0.000811	0.00124	CcSEcCtD
Lansoprazole—Malaise—Azathioprine—Crohn's disease	0.000803	0.00123	CcSEcCtD
Lansoprazole—Flatulence—Mesalazine—Crohn's disease	0.000799	0.00123	CcSEcCtD
Lansoprazole—Leukopenia—Azathioprine—Crohn's disease	0.000797	0.00122	CcSEcCtD
Lansoprazole—Vascular purpura—Prednisone—Crohn's disease	0.000796	0.00122	CcSEcCtD
Lansoprazole—Tension—Mesalazine—Crohn's disease	0.000796	0.00122	CcSEcCtD
Lansoprazole—Dysgeusia—Mesalazine—Crohn's disease	0.000794	0.00122	CcSEcCtD
Lansoprazole—Nervousness—Mesalazine—Crohn's disease	0.000788	0.00121	CcSEcCtD
Lansoprazole—Back pain—Mesalazine—Crohn's disease	0.000784	0.0012	CcSEcCtD
Lansoprazole—Muscle spasms—Mesalazine—Crohn's disease	0.00078	0.0012	CcSEcCtD
Lansoprazole—Vomiting—Mercaptopurine—Crohn's disease	0.000775	0.00119	CcSEcCtD
Lansoprazole—Injury—Prednisone—Crohn's disease	0.000775	0.00119	CcSEcCtD
Lansoprazole—Rash—Mercaptopurine—Crohn's disease	0.000769	0.00118	CcSEcCtD
Lansoprazole—Dermatitis—Mercaptopurine—Crohn's disease	0.000768	0.00118	CcSEcCtD
Lansoprazole—Vision blurred—Mesalazine—Crohn's disease	0.000764	0.00117	CcSEcCtD
Lansoprazole—Tremor—Mesalazine—Crohn's disease	0.00076	0.00117	CcSEcCtD
Lansoprazole—Increased appetite—Prednisone—Crohn's disease	0.000758	0.00116	CcSEcCtD
Lansoprazole—Amnesia—Prednisone—Crohn's disease	0.000758	0.00116	CcSEcCtD
Lansoprazole—Arthralgia—Azathioprine—Crohn's disease	0.000758	0.00116	CcSEcCtD
Lansoprazole—Myalgia—Azathioprine—Crohn's disease	0.000758	0.00116	CcSEcCtD
Lansoprazole—CYP1B1—lymph node—Crohn's disease	0.000754	0.0151	CbGeAlD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000753	0.00116	CcSEcCtD
Lansoprazole—Ill-defined disorder—Mesalazine—Crohn's disease	0.000752	0.00115	CcSEcCtD
Lansoprazole—Anaemia—Mesalazine—Crohn's disease	0.000749	0.00115	CcSEcCtD
Lansoprazole—Discomfort—Azathioprine—Crohn's disease	0.000749	0.00115	CcSEcCtD
Lansoprazole—Angioedema—Mesalazine—Crohn's disease	0.000741	0.00114	CcSEcCtD
Lansoprazole—Purpura—Prednisone—Crohn's disease	0.000739	0.00113	CcSEcCtD
Lansoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.000739	0.0642	CbGpPWpGaD
Lansoprazole—Malaise—Mesalazine—Crohn's disease	0.000731	0.00112	CcSEcCtD
Lansoprazole—Vertigo—Mesalazine—Crohn's disease	0.000729	0.00112	CcSEcCtD
Lansoprazole—Syncope—Mesalazine—Crohn's disease	0.000727	0.00112	CcSEcCtD
Lansoprazole—Leukopenia—Mesalazine—Crohn's disease	0.000726	0.00111	CcSEcCtD
Lansoprazole—Nausea—Mercaptopurine—Crohn's disease	0.000724	0.00111	CcSEcCtD
Lansoprazole—Infection—Azathioprine—Crohn's disease	0.000722	0.00111	CcSEcCtD
Lansoprazole—Palpitations—Mesalazine—Crohn's disease	0.000717	0.0011	CcSEcCtD
Lansoprazole—Loss of consciousness—Mesalazine—Crohn's disease	0.000713	0.00109	CcSEcCtD
Lansoprazole—Osteoarthritis—Prednisone—Crohn's disease	0.000712	0.00109	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000712	0.00109	CcSEcCtD
Lansoprazole—Thrombocytopenia—Azathioprine—Crohn's disease	0.000711	0.00109	CcSEcCtD
Lansoprazole—Cough—Mesalazine—Crohn's disease	0.000708	0.00109	CcSEcCtD
Lansoprazole—Skin disorder—Azathioprine—Crohn's disease	0.000706	0.00108	CcSEcCtD
Lansoprazole—Affect lability—Prednisone—Crohn's disease	0.000701	0.00108	CcSEcCtD
Lansoprazole—Hypertension—Mesalazine—Crohn's disease	0.0007	0.00107	CcSEcCtD
Lansoprazole—Chest pain—Mesalazine—Crohn's disease	0.00069	0.00106	CcSEcCtD
Lansoprazole—Myalgia—Mesalazine—Crohn's disease	0.00069	0.00106	CcSEcCtD
Lansoprazole—Arthralgia—Mesalazine—Crohn's disease	0.00069	0.00106	CcSEcCtD
Lansoprazole—Anxiety—Mesalazine—Crohn's disease	0.000688	0.00106	CcSEcCtD
Lansoprazole—Face oedema—Prednisone—Crohn's disease	0.000688	0.00106	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000686	0.00105	CcSEcCtD
Lansoprazole—CYP3A4—digestive system—Crohn's disease	0.000685	0.0137	CbGeAlD
Lansoprazole—Discomfort—Mesalazine—Crohn's disease	0.000682	0.00105	CcSEcCtD
Lansoprazole—Hypotension—Azathioprine—Crohn's disease	0.000679	0.00104	CcSEcCtD
Lansoprazole—Dry mouth—Mesalazine—Crohn's disease	0.000675	0.00104	CcSEcCtD
Lansoprazole—Mood swings—Prednisone—Crohn's disease	0.000675	0.00104	CcSEcCtD
Lansoprazole—CYP2D6—digestive system—Crohn's disease	0.000674	0.0135	CbGeAlD
Lansoprazole—Confusional state—Mesalazine—Crohn's disease	0.000667	0.00102	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000662	0.00102	CcSEcCtD
Lansoprazole—Anaphylactic shock—Mesalazine—Crohn's disease	0.000662	0.00102	CcSEcCtD
Lansoprazole—Oedema—Mesalazine—Crohn's disease	0.000662	0.00102	CcSEcCtD
Lansoprazole—Infection—Mesalazine—Crohn's disease	0.000657	0.00101	CcSEcCtD
Lansoprazole—Dry skin—Prednisone—Crohn's disease	0.000653	0.001	CcSEcCtD
Lansoprazole—Shock—Mesalazine—Crohn's disease	0.000651	0.000999	CcSEcCtD
Lansoprazole—Nervous system disorder—Mesalazine—Crohn's disease	0.000649	0.000996	CcSEcCtD
Lansoprazole—Hypokalaemia—Prednisone—Crohn's disease	0.000648	0.000995	CcSEcCtD
Lansoprazole—Thrombocytopenia—Mesalazine—Crohn's disease	0.000648	0.000995	CcSEcCtD
Lansoprazole—Tachycardia—Mesalazine—Crohn's disease	0.000646	0.000991	CcSEcCtD
Lansoprazole—Skin disorder—Mesalazine—Crohn's disease	0.000643	0.000987	CcSEcCtD
Lansoprazole—Hyperhidrosis—Mesalazine—Crohn's disease	0.00064	0.000982	CcSEcCtD
Lansoprazole—ABCB1—epithelium—Crohn's disease	0.000637	0.0127	CbGeAlD
Lansoprazole—Anorexia—Mesalazine—Crohn's disease	0.000631	0.000968	CcSEcCtD
Lansoprazole—Muscular weakness—Prednisone—Crohn's disease	0.000628	0.000964	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000628	0.000964	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000627	0.000963	CcSEcCtD
Lansoprazole—Abdominal distension—Prednisone—Crohn's disease	0.00062	0.000952	CcSEcCtD
Lansoprazole—Hypotension—Mesalazine—Crohn's disease	0.000618	0.000949	CcSEcCtD
Lansoprazole—Pancreatitis—Prednisone—Crohn's disease	0.000604	0.000927	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000603	0.000926	CcSEcCtD
Lansoprazole—Feeling abnormal—Azathioprine—Crohn's disease	0.000599	0.000919	CcSEcCtD
Lansoprazole—Insomnia—Mesalazine—Crohn's disease	0.000599	0.000919	CcSEcCtD
Lansoprazole—Paraesthesia—Mesalazine—Crohn's disease	0.000594	0.000912	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000594	0.000912	CcSEcCtD
Lansoprazole—Dyspnoea—Mesalazine—Crohn's disease	0.00059	0.000906	CcSEcCtD
Lansoprazole—Somnolence—Mesalazine—Crohn's disease	0.000588	0.000903	CcSEcCtD
Lansoprazole—Dyspepsia—Mesalazine—Crohn's disease	0.000583	0.000894	CcSEcCtD
Lansoprazole—Neutropenia—Prednisone—Crohn's disease	0.000576	0.000884	CcSEcCtD
Lansoprazole—Decreased appetite—Mesalazine—Crohn's disease	0.000575	0.000883	CcSEcCtD
Lansoprazole—Abdominal pain—Azathioprine—Crohn's disease	0.000574	0.000882	CcSEcCtD
Lansoprazole—Body temperature increased—Azathioprine—Crohn's disease	0.000574	0.000882	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000571	0.000877	CcSEcCtD
Lansoprazole—Fatigue—Mesalazine—Crohn's disease	0.000571	0.000876	CcSEcCtD
Lansoprazole—Erectile dysfunction—Prednisone—Crohn's disease	0.000567	0.00087	CcSEcCtD
Lansoprazole—Pain—Mesalazine—Crohn's disease	0.000566	0.000869	CcSEcCtD
Lansoprazole—Constipation—Mesalazine—Crohn's disease	0.000566	0.000869	CcSEcCtD
Lansoprazole—ABCG2—lymph node—Crohn's disease	0.000561	0.0112	CbGeAlD
Lansoprazole—Weight increased—Prednisone—Crohn's disease	0.00056	0.00086	CcSEcCtD
Lansoprazole—Hyperglycaemia—Prednisone—Crohn's disease	0.000555	0.000853	CcSEcCtD
Lansoprazole—ABCB1—mammalian vulva—Crohn's disease	0.000552	0.011	CbGeAlD
Lansoprazole—Feeling abnormal—Mesalazine—Crohn's disease	0.000545	0.000837	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Prednisone—Crohn's disease	0.000541	0.000831	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000541	0.000831	CcSEcCtD
Lansoprazole—Myocardial infarction—Prednisone—Crohn's disease	0.000538	0.000826	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Prednisone—Crohn's disease	0.000538	0.000826	CcSEcCtD
Lansoprazole—Hypersensitivity—Azathioprine—Crohn's disease	0.000535	0.000822	CcSEcCtD
Lansoprazole—CYP1A1—lymph node—Crohn's disease	0.000533	0.0107	CbGeAlD
Lansoprazole—Urticaria—Mesalazine—Crohn's disease	0.000526	0.000807	CcSEcCtD
Lansoprazole—Abdominal pain—Mesalazine—Crohn's disease	0.000523	0.000803	CcSEcCtD
Lansoprazole—Body temperature increased—Mesalazine—Crohn's disease	0.000523	0.000803	CcSEcCtD
Lansoprazole—Bradycardia—Prednisone—Crohn's disease	0.000502	0.00077	CcSEcCtD
Lansoprazole—Diarrhoea—Azathioprine—Crohn's disease	0.000497	0.000763	CcSEcCtD
Lansoprazole—ABCB1—lymphoid tissue—Crohn's disease	0.000491	0.00981	CbGeAlD
Lansoprazole—Hallucination—Prednisone—Crohn's disease	0.00049	0.000753	CcSEcCtD
Lansoprazole—Hypersensitivity—Mesalazine—Crohn's disease	0.000488	0.000748	CcSEcCtD
Lansoprazole—ABCB1—digestive system—Crohn's disease	0.000485	0.00969	CbGeAlD
Lansoprazole—Connective tissue disorder—Prednisone—Crohn's disease	0.000484	0.000743	CcSEcCtD
Lansoprazole—MAPT—BDNF signaling pathway—KSR1—Crohn's disease	0.000483	0.0419	CbGpPWpGaD
Lansoprazole—Dizziness—Azathioprine—Crohn's disease	0.00048	0.000737	CcSEcCtD
Lansoprazole—Asthenia—Mesalazine—Crohn's disease	0.000475	0.000729	CcSEcCtD
Lansoprazole—Pruritus—Mesalazine—Crohn's disease	0.000468	0.000719	CcSEcCtD
Lansoprazole—Vomiting—Azathioprine—Crohn's disease	0.000462	0.000709	CcSEcCtD
Lansoprazole—Eye disorder—Prednisone—Crohn's disease	0.000461	0.000707	CcSEcCtD
Lansoprazole—Rash—Azathioprine—Crohn's disease	0.000458	0.000703	CcSEcCtD
Lansoprazole—Dermatitis—Azathioprine—Crohn's disease	0.000458	0.000703	CcSEcCtD
Lansoprazole—Headache—Azathioprine—Crohn's disease	0.000455	0.000699	CcSEcCtD
Lansoprazole—Diarrhoea—Mesalazine—Crohn's disease	0.000453	0.000695	CcSEcCtD
Lansoprazole—Angiopathy—Prednisone—Crohn's disease	0.000447	0.000686	CcSEcCtD
Lansoprazole—Immune system disorder—Prednisone—Crohn's disease	0.000445	0.000683	CcSEcCtD
Lansoprazole—Arrhythmia—Prednisone—Crohn's disease	0.00044	0.000676	CcSEcCtD
Lansoprazole—Dizziness—Mesalazine—Crohn's disease	0.000438	0.000672	CcSEcCtD
Lansoprazole—Alopecia—Prednisone—Crohn's disease	0.000436	0.000669	CcSEcCtD
Lansoprazole—Mental disorder—Prednisone—Crohn's disease	0.000432	0.000663	CcSEcCtD
Lansoprazole—Nausea—Azathioprine—Crohn's disease	0.000432	0.000662	CcSEcCtD
Lansoprazole—Erythema—Prednisone—Crohn's disease	0.000429	0.000659	CcSEcCtD
Lansoprazole—Malnutrition—Prednisone—Crohn's disease	0.000429	0.000659	CcSEcCtD
Lansoprazole—Vomiting—Mesalazine—Crohn's disease	0.000421	0.000646	CcSEcCtD
Lansoprazole—Rash—Mesalazine—Crohn's disease	0.000417	0.000641	CcSEcCtD
Lansoprazole—Dermatitis—Mesalazine—Crohn's disease	0.000417	0.00064	CcSEcCtD
Lansoprazole—Headache—Mesalazine—Crohn's disease	0.000415	0.000636	CcSEcCtD
Lansoprazole—Vision blurred—Prednisone—Crohn's disease	0.000404	0.000621	CcSEcCtD
Lansoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.000399	0.0347	CbGpPWpGaD
Lansoprazole—Ill-defined disorder—Prednisone—Crohn's disease	0.000398	0.000611	CcSEcCtD
Lansoprazole—MAPT—MAPK Signaling Pathway—PPP5C—Crohn's disease	0.000397	0.0345	CbGpPWpGaD
Lansoprazole—Anaemia—Prednisone—Crohn's disease	0.000397	0.000609	CcSEcCtD
Lansoprazole—Agitation—Prednisone—Crohn's disease	0.000394	0.000605	CcSEcCtD
Lansoprazole—Nausea—Mesalazine—Crohn's disease	0.000393	0.000603	CcSEcCtD
Lansoprazole—Angioedema—Prednisone—Crohn's disease	0.000392	0.000602	CcSEcCtD
Lansoprazole—Malaise—Prednisone—Crohn's disease	0.000387	0.000594	CcSEcCtD
Lansoprazole—Vertigo—Prednisone—Crohn's disease	0.000385	0.000592	CcSEcCtD
Lansoprazole—Syncope—Prednisone—Crohn's disease	0.000385	0.000591	CcSEcCtD
Lansoprazole—Loss of consciousness—Prednisone—Crohn's disease	0.000377	0.000579	CcSEcCtD
Lansoprazole—Convulsion—Prednisone—Crohn's disease	0.000372	0.000571	CcSEcCtD
Lansoprazole—Hypertension—Prednisone—Crohn's disease	0.00037	0.000569	CcSEcCtD
Lansoprazole—Arthralgia—Prednisone—Crohn's disease	0.000365	0.000561	CcSEcCtD
Lansoprazole—Myalgia—Prednisone—Crohn's disease	0.000365	0.000561	CcSEcCtD
Lansoprazole—Anxiety—Prednisone—Crohn's disease	0.000364	0.000559	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000363	0.000557	CcSEcCtD
Lansoprazole—Discomfort—Prednisone—Crohn's disease	0.000361	0.000554	CcSEcCtD
Lansoprazole—Oedema—Prednisone—Crohn's disease	0.00035	0.000537	CcSEcCtD
Lansoprazole—Anaphylactic shock—Prednisone—Crohn's disease	0.00035	0.000537	CcSEcCtD
Lansoprazole—Infection—Prednisone—Crohn's disease	0.000348	0.000534	CcSEcCtD
Lansoprazole—Shock—Prednisone—Crohn's disease	0.000344	0.000529	CcSEcCtD
Lansoprazole—Nervous system disorder—Prednisone—Crohn's disease	0.000343	0.000527	CcSEcCtD
Lansoprazole—Tachycardia—Prednisone—Crohn's disease	0.000342	0.000525	CcSEcCtD
Lansoprazole—Skin disorder—Prednisone—Crohn's disease	0.00034	0.000522	CcSEcCtD
Lansoprazole—Hyperhidrosis—Prednisone—Crohn's disease	0.000338	0.00052	CcSEcCtD
Lansoprazole—Anorexia—Prednisone—Crohn's disease	0.000334	0.000512	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000319	0.00049	CcSEcCtD
Lansoprazole—Insomnia—Prednisone—Crohn's disease	0.000317	0.000486	CcSEcCtD
Lansoprazole—Paraesthesia—Prednisone—Crohn's disease	0.000314	0.000483	CcSEcCtD
Lansoprazole—Dyspepsia—Prednisone—Crohn's disease	0.000308	0.000473	CcSEcCtD
Lansoprazole—CYP4A11—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000306	0.0266	CbGpPWpGaD
Lansoprazole—Decreased appetite—Prednisone—Crohn's disease	0.000304	0.000467	CcSEcCtD
Lansoprazole—Fatigue—Prednisone—Crohn's disease	0.000302	0.000463	CcSEcCtD
Lansoprazole—Constipation—Prednisone—Crohn's disease	0.000299	0.00046	CcSEcCtD
Lansoprazole—Feeling abnormal—Prednisone—Crohn's disease	0.000289	0.000443	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Prednisone—Crohn's disease	0.000286	0.00044	CcSEcCtD
Lansoprazole—Urticaria—Prednisone—Crohn's disease	0.000278	0.000427	CcSEcCtD
Lansoprazole—Body temperature increased—Prednisone—Crohn's disease	0.000277	0.000425	CcSEcCtD
Lansoprazole—Abdominal pain—Prednisone—Crohn's disease	0.000277	0.000425	CcSEcCtD
Lansoprazole—ABCB1—lymph node—Crohn's disease	0.000277	0.00553	CbGeAlD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000271	0.0236	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—LRRK2—Crohn's disease	0.000268	0.0233	CbGpPWpGaD
Lansoprazole—MAPT—IL-2 Signaling Pathway—IL2RA—Crohn's disease	0.000258	0.0225	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Prednisone—Crohn's disease	0.000258	0.000396	CcSEcCtD
Lansoprazole—Asthenia—Prednisone—Crohn's disease	0.000251	0.000386	CcSEcCtD
Lansoprazole—Pruritus—Prednisone—Crohn's disease	0.000248	0.00038	CcSEcCtD
Lansoprazole—MAPT—Kit receptor signaling pathway—SOCS1—Crohn's disease	0.000246	0.0214	CbGpPWpGaD
Lansoprazole—Diarrhoea—Prednisone—Crohn's disease	0.00024	0.000368	CcSEcCtD
Lansoprazole—Dizziness—Prednisone—Crohn's disease	0.000232	0.000355	CcSEcCtD
Lansoprazole—Vomiting—Prednisone—Crohn's disease	0.000223	0.000342	CcSEcCtD
Lansoprazole—Rash—Prednisone—Crohn's disease	0.000221	0.000339	CcSEcCtD
Lansoprazole—Dermatitis—Prednisone—Crohn's disease	0.000221	0.000339	CcSEcCtD
Lansoprazole—Headache—Prednisone—Crohn's disease	0.000219	0.000337	CcSEcCtD
Lansoprazole—Nausea—Prednisone—Crohn's disease	0.000208	0.000319	CcSEcCtD
Lansoprazole—CYP1B1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000197	0.0171	CbGpPWpGaD
Lansoprazole—MAPT—IL-5 Signaling Pathway—JAK2—Crohn's disease	0.000181	0.0157	CbGpPWpGaD
Lansoprazole—CYP4A11—PPARA activates gene expression—FADS1—Crohn's disease	0.000174	0.0151	CbGpPWpGaD
Lansoprazole—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.00017	0.0148	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000161	0.014	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000161	0.014	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000143	0.0124	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000143	0.0124	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000138	0.012	CbGpPWpGaD
Lansoprazole—MAPT—IL-5 Signaling Pathway—STAT3—Crohn's disease	0.000133	0.0115	CbGpPWpGaD
Lansoprazole—MAPT—Kit receptor signaling pathway—JAK2—Crohn's disease	0.000132	0.0115	CbGpPWpGaD
Lansoprazole—MAPT—Notch Signaling Pathway—JAK2—Crohn's disease	0.000129	0.0112	CbGpPWpGaD
Lansoprazole—MAPT—IL-2 Signaling Pathway—STAT3—Crohn's disease	0.000128	0.0111	CbGpPWpGaD
Lansoprazole—CYP1B1—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000122	0.0106	CbGpPWpGaD
Lansoprazole—CYP1A1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000121	0.0106	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—RASGRP1—Crohn's disease	0.000118	0.0102	CbGpPWpGaD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000117	0.0102	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TAB1—Crohn's disease	0.000115	0.01	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000113	0.00984	CbGpPWpGaD
Lansoprazole—MAPT—LPA receptor mediated events—CXCL8—Crohn's disease	0.000113	0.00984	CbGpPWpGaD
Lansoprazole—CYP2C8—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000111	0.00968	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00011	0.00955	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000101	0.00877	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.0001	0.0087	CbGpPWpGaD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	9.94e-05	0.00864	CbGpPWpGaD
Lansoprazole—CYP2C18—Metapathway biotransformation—GPX4—Crohn's disease	9.82e-05	0.00854	CbGpPWpGaD
Lansoprazole—MAPT—Kit receptor signaling pathway—STAT3—Crohn's disease	9.72e-05	0.00844	CbGpPWpGaD
Lansoprazole—MAPT—Notch Signaling Pathway—STAT3—Crohn's disease	9.46e-05	0.00822	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—IL1B—Crohn's disease	9.18e-05	0.00797	CbGpPWpGaD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	9.07e-05	0.00788	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	8.99e-05	0.00781	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.92e-05	0.00775	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	8.47e-05	0.00736	CbGpPWpGaD
Lansoprazole—CYP4A11—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.23e-05	0.00715	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	7.75e-05	0.00673	CbGpPWpGaD
Lansoprazole—CYP1A1—Estrogen Receptor Pathway—STAT3—Crohn's disease	7.49e-05	0.00651	CbGpPWpGaD
Lansoprazole—CYP1B1—Metapathway biotransformation—GPX4—Crohn's disease	7.24e-05	0.00629	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.05e-05	0.00613	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—FADS1—Crohn's disease	6.9e-05	0.006	CbGpPWpGaD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	6.76e-05	0.00587	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—TNF—Crohn's disease	6.66e-05	0.00579	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	6.6e-05	0.00573	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—JAK2—Crohn's disease	6.48e-05	0.00563	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6e-05	0.00521	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	5.92e-05	0.00514	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	5.67e-05	0.00493	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	5.4e-05	0.00469	CbGpPWpGaD
Lansoprazole—CYP1B1—Arachidonic acid metabolism—PTGS2—Crohn's disease	5.31e-05	0.00461	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	5.28e-05	0.00458	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—IL1B—Crohn's disease	5.02e-05	0.00436	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	4.98e-05	0.00433	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.87e-05	0.00423	CbGpPWpGaD
Lansoprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	4.77e-05	0.00415	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—STAT3—Crohn's disease	4.76e-05	0.00414	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL17A—Crohn's disease	4.72e-05	0.0041	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.67e-05	0.00406	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	4.66e-05	0.00405	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.55e-05	0.00395	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—GPX4—Crohn's disease	4.46e-05	0.00388	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL12B—Crohn's disease	4.39e-05	0.00382	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.38e-05	0.0038	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	4.09e-05	0.00355	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TNF—Crohn's disease	3.88e-05	0.00337	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.86e-05	0.00336	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.83e-05	0.00333	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	3.83e-05	0.00333	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	3.65e-05	0.00317	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	3.64e-05	0.00317	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TNF—Crohn's disease	3.64e-05	0.00316	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ALB—Crohn's disease	3.6e-05	0.00313	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	3.57e-05	0.0031	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	3.49e-05	0.00303	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	3.36e-05	0.00292	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.34e-05	0.00291	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.34e-05	0.00291	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	3.33e-05	0.00289	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.29e-05	0.00286	CbGpPWpGaD
Lansoprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.27e-05	0.00284	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	3.25e-05	0.00282	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ALB—Crohn's disease	3.21e-05	0.00279	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL10—Crohn's disease	3.21e-05	0.00279	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PLA2G4F—Crohn's disease	3.14e-05	0.00273	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.01e-05	0.00262	CbGpPWpGaD
Lansoprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	3e-05	0.0026	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	2.86e-05	0.00249	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	2.84e-05	0.00247	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.82e-05	0.00245	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.8e-05	0.00243	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PLA2G4F—Crohn's disease	2.75e-05	0.00239	CbGpPWpGaD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.67e-05	0.00232	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—MTMR3—Crohn's disease	2.67e-05	0.00232	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.57e-05	0.00223	CbGpPWpGaD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.44e-05	0.00212	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.38e-05	0.00207	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	2.36e-05	0.00205	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.36e-05	0.00205	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.36e-05	0.00205	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MTMR3—Crohn's disease	2.33e-05	0.00203	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	2.32e-05	0.00202	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.29e-05	0.00199	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	2.23e-05	0.00194	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	2.19e-05	0.00191	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.18e-05	0.0019	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.09e-05	0.00181	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.08e-05	0.00181	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.08e-05	0.00181	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—FADS1—Crohn's disease	2.08e-05	0.00181	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	2.07e-05	0.0018	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PLA2G4F—Crohn's disease	2.02e-05	0.00176	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.02e-05	0.00175	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GPX4—Crohn's disease	1.95e-05	0.00169	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.95e-05	0.00169	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IFNG—Crohn's disease	1.89e-05	0.00164	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GCKR—Crohn's disease	1.88e-05	0.00164	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.85e-05	0.00161	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PLA2G4F—Crohn's disease	1.84e-05	0.0016	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—FADS1—Crohn's disease	1.82e-05	0.00158	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.81e-05	0.00157	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.81e-05	0.00157	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.78e-05	0.00155	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.78e-05	0.00154	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	1.76e-05	0.00153	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.74e-05	0.00151	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MTMR3—Crohn's disease	1.72e-05	0.0015	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GPX4—Crohn's disease	1.7e-05	0.00148	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.7e-05	0.00148	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL1B—Crohn's disease	1.68e-05	0.00146	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GCKR—Crohn's disease	1.64e-05	0.00143	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.59e-05	0.00138	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MTMR3—Crohn's disease	1.57e-05	0.00136	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.52e-05	0.00132	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.52e-05	0.00132	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.5e-05	0.00131	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	1.5e-05	0.00131	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.42e-05	0.00123	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.38e-05	0.0012	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.34e-05	0.00117	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—FADS1—Crohn's disease	1.34e-05	0.00117	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.3e-05	0.00113	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.27e-05	0.00111	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GPX4—Crohn's disease	1.26e-05	0.00109	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	1.25e-05	0.00108	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—Crohn's disease	1.22e-05	0.00106	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—FADS1—Crohn's disease	1.22e-05	0.00106	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GCKR—Crohn's disease	1.21e-05	0.00105	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.18e-05	0.00103	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.18e-05	0.00102	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	1.14e-05	0.000993	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GPX4—Crohn's disease	1.14e-05	0.000993	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.13e-05	0.000978	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.11e-05	0.000962	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GCKR—Crohn's disease	1.1e-05	0.000959	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTMR3—Crohn's disease	1.06e-05	0.000921	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	1.02e-05	0.000886	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PLA2G4F—Crohn's disease	9.96e-06	0.000865	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTMR3—Crohn's disease	9.72e-06	0.000844	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	9.38e-06	0.000815	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	9.3e-06	0.000808	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	8.93e-06	0.000776	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTMR3—Crohn's disease	8.67e-06	0.000754	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.67e-06	0.000753	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTMR3—Crohn's disease	8.47e-06	0.000736	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—FADS1—Crohn's disease	8.26e-06	0.000718	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTMR3—Crohn's disease	7.98e-06	0.000693	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	7.95e-06	0.000691	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTMR3—Crohn's disease	7.91e-06	0.000687	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GPX4—Crohn's disease	7.73e-06	0.000672	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.58e-06	0.000659	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—FADS1—Crohn's disease	7.57e-06	0.000658	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	7.5e-06	0.000651	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GCKR—Crohn's disease	7.47e-06	0.000649	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX4—Crohn's disease	7.09e-06	0.000616	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GCKR—Crohn's disease	6.85e-06	0.000595	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTMR3—Crohn's disease	6.76e-06	0.000587	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—FADS1—Crohn's disease	6.76e-06	0.000587	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—FADS1—Crohn's disease	6.6e-06	0.000573	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX4—Crohn's disease	6.33e-06	0.00055	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—FADS1—Crohn's disease	6.22e-06	0.00054	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX4—Crohn's disease	6.18e-06	0.000537	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—FADS1—Crohn's disease	6.16e-06	0.000535	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	6.13e-06	0.000533	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GCKR—Crohn's disease	6.11e-06	0.000531	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	6.03e-06	0.000524	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ALB—Crohn's disease	5.99e-06	0.00052	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GCKR—Crohn's disease	5.96e-06	0.000518	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX4—Crohn's disease	5.82e-06	0.000506	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX4—Crohn's disease	5.77e-06	0.000501	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GCKR—Crohn's disease	5.62e-06	0.000488	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GCKR—Crohn's disease	5.57e-06	0.000484	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.34e-06	0.000464	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—FADS1—Crohn's disease	5.27e-06	0.000458	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—Crohn's disease	5.24e-06	0.000455	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—Crohn's disease	5.24e-06	0.000455	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.22e-06	0.000453	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX4—Crohn's disease	4.93e-06	0.000428	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.89e-06	0.000425	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCKR—Crohn's disease	4.76e-06	0.000414	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.67e-06	0.000406	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—Crohn's disease	4.58e-06	0.000398	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.37e-06	0.00038	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.28e-06	0.000372	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FADS1—Crohn's disease	4.06e-06	0.000353	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.05e-06	0.000352	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.98e-06	0.000346	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—Crohn's disease	3.86e-06	0.000335	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.82e-06	0.000332	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX4—Crohn's disease	3.81e-06	0.000331	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCKR—Crohn's disease	3.68e-06	0.000319	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—Crohn's disease	3.51e-06	0.000305	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.48e-06	0.000303	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.4e-06	0.000296	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—Crohn's disease	3.38e-06	0.000293	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—Crohn's disease	3.07e-06	0.000267	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.98e-06	0.000259	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—Crohn's disease	2.38e-06	0.000207	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—Crohn's disease	2.18e-06	0.000189	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—Crohn's disease	2.08e-06	0.000181	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—Crohn's disease	1.95e-06	0.000169	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.91e-06	0.000166	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—Crohn's disease	1.9e-06	0.000165	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—Crohn's disease	1.79e-06	0.000155	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—Crohn's disease	1.77e-06	0.000154	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.7e-06	0.000148	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—Crohn's disease	1.66e-06	0.000144	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.57e-06	0.000136	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.55e-06	0.000135	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—Crohn's disease	1.52e-06	0.000132	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.33e-06	0.000115	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—Crohn's disease	1.17e-06	0.000102	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.02e-06	8.89e-05	CbGpPWpGaD
